Compare ACDC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACDC | AORT |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2021 | 1996 |
| Metric | ACDC | AORT |
|---|---|---|
| Price | $4.80 | $25.11 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.50 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 1.4M | 763.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $1,941,800,000.00 | $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | $11.50 | $11.20 |
| P/E Ratio | ★ N/A | $858.17 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $3.08 | $19.16 |
| 52 Week High | $8.43 | $48.25 |
| Indicator | ACDC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 37.54 | 58.20 |
| Support Level | $4.73 | $19.49 |
| Resistance Level | $5.69 | $38.02 |
| Average True Range (ATR) | 0.36 | 1.11 |
| MACD | 0.00 | 0.32 |
| Stochastic Oscillator | 15.33 | 80.06 |
ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.